Invasiveness and angiogenetic potential of BC cells are supported by TLR4-mediated signaling pathways (Ahmed et al., 2013; Yang et al., 2014), leading to pro-tumoral effects, which may be TP53 dependent (Haricharan and Brown, 2015). The gene discussed is TLR4; the disease is breast cancer.